Achilles Therapeutics Plc Overview

Achilles Therapeutics Plc Research & Development

Research & Development expenses for ACHL.

Quarterly R&D Expenses

$16.40M

↑ 11.45% YoY

As of Sep 30, 2024

Annual R&D Expenses (TTM)

$56.21M

↓ 8.2% YoY

Trailing 12 months ending Sep 30, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin